Product Information
MEFLOQUINE HCL 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.0689 per EA under NDC 00555017178. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555017178
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEFLOQUINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076392On Market Since
1/6/2004
Pharmacological Classes
Price Statistics
The NADAC for MEFLOQUINE HCL 250 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0689 per EA |
|---|---|
| All-time high | $6.3637 (Sep 10, 2014) |
| All-time low | $2.8103 (Aug 23, 2023) |
| 52-week high | $5.0310 |
| 52-week low | $3.1377 |
| Median price | $4.0719 |
| Average price | $4.2139 |
| Largest weekly change | +52.2% (Aug 20, 2025) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEFLOQUINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEFLOQUINE HCL 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $4.0689 per EA (NDC 00555017178), effective Jun 24, 2026.
How has the price of MEFLOQUINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEFLOQUINE HCL 250 MG TABLET has declined 16.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEFLOQUINE HCL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for MEFLOQUINE HCL 250 MG TABLET has ranged from a low of $2.8103 (Aug 23, 2023) to a high of $6.3637 (Sep 10, 2014), with a median of $4.0719 per EA.
Are there cheaper alternatives to MEFLOQUINE HCL 250 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MEFLOQUINE HCL 250 MG TABLET, but none are currently priced below it.
Who manufactures MEFLOQUINE HCL 250 MG TABLET?
MEFLOQUINE HCL 250 MG TABLET (NDC 00555017178) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification